When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMMP - Immutep gets Japanese patent related to autoimmune disease drug candidate IMP761
Immutep Limited
Immutep ( NASDAQ: IMMP ) said it received a patent from the Japanese Patent Office related to its pre-clinical product candidate IMP761.
The patent number number 7074341 titled 'Anti-LAG-3 Antibodies' is related to pharmaceutical compositions comprising IMP761 and the use of the compositions to treat T-cell mediated inflammatory and autoimmune diseases, according to the company's July 6 press release.